Cyclopharm Ltd. | Cash Flow
Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
9,640.10
4,065.60
4,793.00
891.40
1,524.60
35.50
Depreciation, Depletion & Amortization
643.10
266.00
144.20
106.40
318.10
510.20
Other Funds
3.30
0.30
-
-
-
747.10
Funds from Operations
689.90
3,594.20
5,116.00
258.80
89.50
216.90
Changes in Working Capital
495.20
874.60
961.10
913.60
192.10
890.40
Net Operating Cash Flow
1,185.10
4,468.80
4,154.80
654.80
281.70
1,107.30
Capital Expenditures
663.50
19.40
651.70
2,221.00
1,709.50
Sale of Fixed Assets & Businesses
-
-
-
-
1,176.00
Purchase/Sale of Investments
-
60.00
-
-
-
Net Investing Cash Flow
1,209.10
238.80
651.70
2,221.00
1,536.60
Cash Dividends Paid - Total
-
-
278.30
556.60
600.10
Issuance/Reduction of Debt, Net
1,204.30
2,171.30
48.40
-
-
Net Financing Cash Flow
1,207.60
2,171.50
326.70
754.00
5,828.50
Net Change in Cash
1,125.90
2,047.80
3,176.60
1,854.20
4,098.90
Free Cash Flow
521.60
4,449.30
4,142.40
1,140.40
922.80
Deferred Taxes & Investment Tax Credit
1.20
4.30
829.20
199.40
193.80
55.40
Net Assets from Acquisitions
-
-
-
-
1,003.00
Change in Capital Stock
-
-
-
-
6,588.80
Exchange Rate Effect
105.70
10.70
0.10
466.00
88.70
Other Uses
545.60
279.30
-
-
-
About Cyclopharm
View Profile
